Rechallenge of ponatinib in chronic myeloid leukaemia after hepatotoxicity.

Rechallenge of ponatinib in chronic myeloid leukaemia after hepatotoxicity. Hong Kong Med J. 2019 Apr;25(2):162-163 Authors: Boo YL, Liam CCK, Toh SG, Lim SM PMID: 30971509 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30971509?dopt=Abstract

Source: Hong Kong Medical Journal - April 13, 2019 Category: General Medicine Tags: Hong Kong Med J Source Type: research

More News: Chronic Leukemia | Chronic Myeloid Leukaemia | General Medicine | Hong Kong Health | Leukemia